Oncoinvent ASA (0RU5.L) LSE

Currency In NOK

Oncoinvent ASA

Address

Gullhaugveien 7

Oslo, PS 0484

Norway

Phone

47 55 96 11 59

Website

https://www.oncoinvent.com

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

December 13, 2017

Key Executives

Name	Title	Pay	Year Born
Oystein Soug	Chief Executive Officer	4.59M	1969
Ramzi Amri	Chief Financial Officer	1.86M	N/A
Stian Brekke	Head of Regulatory Affairs	1.95M	N/A
Kristine Lofthus	Chief Production Officer	2.1M	N/A
Anne-Kirsti Aksnes	Chief Clinical Officer	2.4M	N/A
Gro Elisabeth Hjellum	Chief Operating Officer	2.82M	N/A
Anne Cecile Alvik	Head of Quality Assurance & Employee Representative Director	2.85M	N/A
Kari Myren	Chief Medical Officer	2.97M	N/A
Kaja Tunhovd Johansen	Head of Quality Control	0	N/A

Description

Oncoinvent ASA is a biopharmaceutical firm dedicated to creating novel therapies for cancer. The company concentrates its efforts on building a diverse range of AXL kinase inhibitors. Its flagship product, bemcentinib, stands out as a highly selective, orally administered small molecule designed to inhibit AXL. James Bradley Lorens and David R. Micklem established the company on December 21, 2007, and it is based in Bergen, Norway.